Published onNovember 28, 2022New initiative to INDICATE cancer riskinterdisciplinary projectMathOncoHeidelbergLynch syndromeimmune systemI am proud to be part of a new international collaborative initiative, called INDICATE, to unravel the role of the Human Leukocyte Antigen type as a cancer risk modifier in individuals with Lynch syndrome.
